A comparison between the efficacy of dydrogesterone and calcium plus vitamin D in improving women's general health

African Journal of Psychiatry (South Africa)

Volumn 13, Issue 3, 2010, Pages 218-224

  Khajehei, M ^a   Abdali, K ^a   Tabatabaee, H R ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium plus vitamin D; Dydrogesterone; General health; Women

Indexed keywords

CALCIUM; CALICIUM; DYDROGESTERONE; PLACEBO; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; ARTICLE; BREAST TENDERNESS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HEALTH PROMOTION; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; MENTAL HEALTH; NAUSEA; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SOUTH AFRICA; UNIVERSITY STUDENT; VERTIGO; WOMEN'S HEALTH;

ADULT; BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DYDROGESTERONE; FEMALE; HEALTH STATUS; HUMANS; MENSTRUAL CYCLE; PROGESTINS; QUESTIONNAIRES; TREATMENT OUTCOME; VITAMIN D; WOMEN'S HEALTH; YOUNG ADULT;

EID: 77957928784     PISSN: 19948220     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. http://www.who.int/topics/mental_health/en/
2. http://www.afro.who.int/mentalhealth/overview.html
3. Steiner M, Dunna E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord 2003;74:67-83.
4. Paul SM, Purdy RH., Neuroactive steroids. FASEB J 1992; 6: 231-232.
5. Lambert JJ, Belelli D, Harney SC, Peters JA, Frenguelli BG. Modulation of native and recombinant GABAA receptors by endogenous and synthetic neuroactive steroids. Brain Res Rev 2001; 37: 68-80.
6. Lovick TA. Plasticity of GABAA receptor subunit expression during the oestrous cycle of the rat: implications for premenstrual syndrome in women. Experimental Physiology 2006; 91(4): 655-660.
7. Smith SS, Gong QH. Neurosteroid administration and withdrawal alter GABAA receptor kinetics in CA1 hippocampus of female rats. J Physiol 2005; 564: 421-436.
8. Olsson M, Ho HP, Annerbrink K, Melchior LK, Hedner J, Eriksson E. Association between estrus cycle-related changes in respiration and estrus cycle-related aggression in outbred female Wistar rats. Neuropsychopharmacology 2003; 28: 704-710.
9. Chrouso GP. The gonadal hormones & inhibitors. In: Katzung BG, ed. Basic and Clinical Pharmacology. 9th ed. New York, NY, USA: McGraw-Hill; 2004: 669-672.
10. Shaw RW, Soutter WP, Staton S. Gynecology. St. Louis: Elsevier Mosby. 2003: 407-10.
11. Thys-Jacobs S, Starkey P, Bernstein D. Premenstrual syndrome study Group. Calcium carbonate and the premenstrual syndrome: Effect on premenstrual and menstrual symptoms. Am J obstet Gynecol 1998; 179: 444-452.
12. Thys-Jacobs S. Micronutrients and the premenstrual syndrome: the case for calcium. J Am Coll Nutr 2000;19:220-227.
13. Thys-Jacobs S, Alvir MJ. Calcium-regulating hormones across the menstrual cycle: evidence of a secondary hyperparathyroidism in women with PMS. J Clin Endocrinol Metab 1995; 80: 2227-2232.
14. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357: 266-81.
15. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003; 118: 641-53.
16. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrin 2002;13: 100-105.
17. Holick MF. Vitamin D. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ. Modern nutrition in health and disease. 10th ed: Lippincott Williams and Wilkins, Baltimore, 2006: 376-395.
18. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2007; 26: 551-4.
19. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, et al. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008;65:508-12.
20. Goldberg DP. The detection of psychiatric illness by questionnaire, A technique for the identification and assessment of non-psychotic psychiatric illness. (Maudsley Monographs No. 21), London: Oxford University Press, 1972.
21. Goldberg D, William P. A user guide to general health questionnaire. Windsor, NFER - Nelson, 1988.
22. Maruyama S, Sato H, Morimoto K. Relationship between work-life satisfaction, health practice and primary symptoms/problems. Nippon Eiseigaku Zasshi 1991; 45: 1082-94.
23. Halbreich U. The etiology, biology and evolving pathology of premenstrual syndrome. Psychoneuroendocrinology 2003; 28(3): 55-99.
24. Klein P. Mood and the menopause. In: Studd J. The management of menopause, London: Parthenon Publishing Group, 2003: 95-109.
25. Bitzer J. Progesterone, progestogens and psychosomatic health of the climacteric woman. Maturitas, Article in Press.
26. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang JM, et al. Progesterone receptors: form and function in brain, Neuroendocrinology 2008; 29: 313-339.
27. Hellberg D, Claesson B, Nilsson S. Premenstrual syndrome: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate. Int J Gynecol Obstetric 1991; 34: 243-248.
28. Fu ML, Lieyueh Cheng, Tu SH, Pan WH. Association between Unhealthful Eating Patterns and Unfavorable Overall School Performance in Children. Journal of the American Dietetic Association 2007; 107(11):1935-1943.
29. Jablonski N. The evolution of human skin and skin color, Annu Rev Anthropol 2004; 33: 585-623.
30. Fink M, Taylor MA. Catatonia. A clinician's guide to treatment. Cambridge: Cambridge University Press, 2003:194-195.
31. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003; 118: 641-653.
32. Berk M, Jacka FN, Williams LJ, Ng F, Dodd S, Pasco JA. Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample. Aust N Z J Psychiatry 2008; 42(10): 874-8.
33. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006;14(12):1032-40.
34. Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl) 1998;135(4):319-23.
35. Sonnenberg J, Luine VN, Krey LC, et al.. 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology 1986;118:1433-9.
36. Wang Y, Chiang YH, Su TP, et al.. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 2000;39:873-80.
37. Brewer LD, Thibault V, Chen KC, et al.. Vitamin D hormone confers neuroprotection in parallel with downregulation of Ltype calcium channel expression in hippocampal neurons. J Neurosci 2001;21:98-108.